How Hyperion DeFi, Inc. plans to refinance traditional debt through a HyperLend lending pool on HyperEVM
Hyperion DeFi launches a HyperLend lending pool to refinance debt at lower cost using DeFi infrastructure. Discover how this could reshape institutional crypto credit.
From premiums to blockchain: why Aon plc is experimenting with stablecoin payments
Aon plc tests stablecoin insurance premium payments using USDC and PYUSD. Discover how blockchain settlement could reshape insurance finance.
Can Mineros S.A. unlock the Tolima gold system after AngloGold Ashanti’s exit?
Mineros S.A. acquires a Tolima gold exploration project from AngloGold Ashanti. Discover what this deal could mean for Colombia’s mining future.
Arthur J. Gallagher & Co. acquires S Philips to deepen surety bond expertise across western U.S. markets
Arthur J. Gallagher & Co. acquires S Philips Surety & Insurance Services to strengthen its surety bond brokerage network across western U.S. markets. Read more.
Can La Rosa Holdings Corp.’s AI pivot transform a real estate platform into a data center infrastructure player?
La Rosa Holdings Corp. plans to acquire AI infrastructure developer Consensus Core Technologies. Discover what the deal means for the AI data center market.
Powerus merger positions Aureus Greenway Holdings inside growing U.S. defense drone ecosystem (NASDAQ: AGH)
Aureus Greenway and Powerus plan a merger to create a U.S. drone manufacturing platform. Discover what the deal means for defense autonomy markets.
Can RNA interference expand beyond rare diseases through Tenaya–Alnylam cardiovascular research? (NASDAQ: ALNY, NASDAQ: TNYA)
Tenaya Therapeutics and Alnylam Pharmaceuticals partner to discover RNAi drug targets for cardiovascular disease. Read what this biotech deal could mean.
How petrelintide’s tolerability profile could reshape patient adherence in obesity pharmacotherapy
Can petrelintide improve adherence in obesity treatment? Discover how Zealand Pharma’s therapy could reshape the weight-loss drug market.
GMP psilocybin manufacturing supports growing psychedelic clinical pipeline
Psyence Biomedical Ltd. exports GMP psilocybin for a Phase IIb cancer trial. Discover what this means for psychedelic medicine and biotech investors.
Diana Shipping escalates Genco acquisition fight with $1.4bn financing backing (NYSE: DSX, NYSE: GNK)
Diana Shipping raises its bid for Genco Shipping with $1.4B financing and Star Bulk support. Discover what the takeover fight means for dry bulk shipping.